FIS
48
-2
HBI
56
11
IP
54
-13
KR
49
11
XRX
45
-3
ROST
70
-3
BK
66
5
DTE
47
2
VNO
52
3
EQIX
48
3
RCL
73
-4
MCK
70
-3
AON
45
6
LRCX
75
-3
TAP
41
-2
UPS
46
-4
AES
55
3
SRCL
60
3
PEP
63
22
SYF
86
-4
FIS
48
-2
HBI
56
11
IP
54
-13
KR
49
11
XRX
45
-3
ROST
70
-3
BK
66
5
DTE
47
2
VNO
52
3
EQIX
48
3
RCL
73
-4
MCK
70
-3
AON
45
6
LRCX
75
-3
TAP
41
-2
UPS
46
-4
AES
55
3
SRCL
60
3
PEP
63
22
SYF
86
-4
Financhill
Back

GT Biopharma Vs. Viking Therapeutics Industry Stock Comparison

Sell
29

GTBP
GT Biopharma

Last Price:
2.83
Seasonality Move:
0.59%
Sell
44

VKTX
Viking Therapeutics

Last Price:
52.96
Seasonality Move:
1.76%
Sell
29
GT Biopharma (GTBP) is a Sell

Is GT Biopharma a Buy, Sell or Hold?

  • The current GT Biopharma [GTBP] share price is $2.82. The Score for GTBP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • GTBP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GTBP Stock Price Chart

What is GT Biopharma's stock price today?

  • The GT Biopharma share price today is $2.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $50.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

GTBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 42.25 Sell
Chaikin Money Flow: -401841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 3.79) Sell
Bollinger Bands (100): (3.14 - 4.64) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.32 Sell
Relative Strength Index (14 RSI): 38.16 Sell
Chaikin Money Flow: 2857375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.57 - 61.31) Sell
Bollinger Bands (100): (46.52 - 79.44) Sell

GTBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.93 Sell
20-day SMA: 3.14 Sell
50-day SMA: 3.47 Sell
200-day SMA: 5.55 Sell
8-day EMA: 2.95 Sell
20-day EMA: 3.14 Sell
50-day EMA: 3.51 Sell
200-day EMA: 7.13 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.48 Buy
20-day SMA: 54.1 Sell
50-day SMA: 63.93 Sell
200-day SMA: 39 Buy
8-day EMA: 50.61 Buy
20-day EMA: 54.34 Sell
50-day EMA: 59.63 Sell
200-day EMA: 45.62 Buy

GT Biopharma Earnings Growth & GTBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

GT Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):